Your browser is no longer supported. Please, upgrade your browser.
DHR Danaher Corporation monthly Stock Chart
DHR [NYSE]
Danaher Corporation
IndexS&P 500 P/E52.90 EPS (ttm)3.88 Insider Own0.50% Shs Outstand705.10M Perf Week0.79%
Market Cap145.92B Forward P/E31.99 EPS next Y6.42 Insider Trans-11.18% Shs Float629.27M Perf Month10.75%
Income2.80B PEG4.06 EPS next Q1.36 Inst Own79.90% Short Float1.11% Perf Quarter27.24%
Sales17.52B P/S8.33 EPS this Y-2.20% Inst Trans-0.15% Short Ratio2.40 Perf Half Y26.80%
Book/sh46.79 P/B4.39 EPS next Y16.88% ROA5.10% Target Price219.00 Perf Year45.79%
Cash/sh7.80 P/C26.34 EPS next 5Y13.02% ROE11.10% 52W Range119.60 - 207.39 Perf YTD33.83%
Dividend0.72 P/FCF45.92 EPS past 5Y7.60% ROI4.70% 52W High-0.96% Beta0.95
Dividend %0.35% Quick Ratio1.70 Sales past 5Y6.80% Gross Margin55.30% 52W Low71.74% ATR4.03
Employees60000 Current Ratio2.20 Sales Q/Q19.20% Oper. Margin20.90% RSI (14)73.66 Volatility1.60% 2.00%
OptionableYes Debt/Eq0.68 EPS Q/Q38.40% Profit Margin19.30% Rel Volume0.46 Prev Close205.69
ShortableYes LT Debt/Eq0.68 EarningsJul 23 BMO Payout14.50% Avg Volume2.90M Price205.40
Recom1.70 SMA204.57% SMA5012.51% SMA20029.63% Volume1,345,474 Change-0.14%
Jun-16-20Upgrade Wolfe Research Peer Perform → Outperform
Apr-02-20Downgrade Wolfe Research Outperform → Peer Perform $154
Mar-26-20Upgrade RBC Capital Mkts Sector Perform → Outperform $151 → $157
Feb-03-20Reiterated Needham Buy $167 → $187
Jan-08-20Initiated Wells Fargo Overweight $170
Jan-07-20Initiated Citigroup Buy $180
Nov-15-19Resumed Stifel Hold
Oct-28-19Reiterated Needham Buy $155 → $152
Oct-14-19Resumed Credit Suisse Outperform $151
Jul-19-19Reiterated Needham Buy $142 → $155
Jun-11-19Initiated Piper Jaffray Neutral
May-30-19Initiated Wolfe Research Outperform
Apr-17-19Reiterated Needham Buy $138 → $141
Feb-28-19Reiterated Needham Buy $114 → $138
Feb-25-19Upgrade Janney Neutral → Buy
Jan-03-19Initiated Needham Buy $114
Apr-20-18Reiterated Stifel Buy $108 → $114
Feb-15-18Initiated Barclays Overweight $110
Sep-26-17Resumed Goldman Neutral $83
Jul-13-17Initiated Wells Fargo Market Perform
Aug-07-20 12:24PM  
Aug-02-20 10:53AM  
Jul-31-20 12:58PM  
12:25PM  
Jul-30-20 09:50AM  
Jul-29-20 12:20PM  
Jul-28-20 12:00PM  
Jul-27-20 07:00AM  
Jul-23-20 04:06PM  
03:00PM  
12:13PM  
08:59AM  
08:00AM  
07:30AM  
07:10AM  
06:00AM  
Jul-21-20 04:52PM  
12:00PM  
09:20AM  
Jul-19-20 03:00PM  
Jul-17-20 08:50PM  
09:15AM  
Jul-16-20 12:32PM  
10:59AM  
07:00AM  
Jul-14-20 08:33AM  
Jul-13-20 04:15PM  
Jul-09-20 12:30PM  
12:10PM  
11:00AM  
Jul-07-20 09:54AM  
Jul-06-20 04:33PM  
04:30PM  
Jul-02-20 08:30PM  
05:21PM  
Jul-01-20 02:37PM  
Jun-29-20 09:41AM  
09:13AM  
08:00AM  
Jun-28-20 07:00AM  
Jun-26-20 09:25PM  
Jun-19-20 06:01AM  
Jun-14-20 06:49PM  
Jun-09-20 07:00AM  
Jun-08-20 09:41AM  
Jun-07-20 11:28AM  
Jun-05-20 01:36PM  
11:32AM  
May-29-20 09:44AM  
May-28-20 12:06PM  
May-26-20 02:04PM  
May-22-20 11:18AM  
May-19-20 10:57AM  
May-18-20 11:49AM  
11:28AM  
May-16-20 09:15AM  
May-15-20 08:18AM  
May-14-20 05:02PM  
07:40AM  
May-13-20 03:34PM  
May-12-20 04:10PM  
11:51AM  
May-08-20 06:35PM  
02:27PM  
01:15AM  
May-07-20 06:00PM  
12:18PM  
09:55AM  
08:52AM  
08:40AM  
04:46AM  
May-06-20 06:05PM  
04:10PM  
04:10PM  
10:52AM  
May-05-20 04:10PM  
10:06AM  
May-04-20 08:55AM  
May-01-20 12:29PM  
Apr-30-20 12:33PM  
12:10PM  
Apr-29-20 12:30PM  
Apr-23-20 05:48PM  
Apr-17-20 11:03AM  
Apr-15-20 09:04AM  
Apr-14-20 09:38AM  
Apr-13-20 10:10AM  
09:46AM  
07:40AM  
06:56AM  
06:45AM  
05:14AM  
Apr-10-20 02:41PM  
Apr-09-20 12:30PM  
06:00AM  
Apr-06-20 02:16PM  
08:57AM  
Apr-03-20 04:45PM  
12:05PM  
Apr-02-20 02:43AM  
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments; Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology and molecular diagnostics products. This segment offers analytical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides equipment, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
McGrew MatthewEVP & Chief Financial OfficerJul 29Sale203.427,4571,516,92512,387Jul 30 07:13 PM
King WilliamSVP, Strategic DevelopmentJul 28Option Exercise54.3126,9821,465,36740,339Jul 29 05:11 PM
King WilliamSVP, Strategic DevelopmentJul 28Sale199.0926,9825,371,87821,589Jul 29 05:11 PM
LOHR WALTER GDirectorJul 28Sale198.5657,00011,317,692391,000Jul 29 05:10 PM
HEFNER LINDA PDirectorJul 27Option Exercise28.9811,014319,18638,255Jul 28 06:13 PM
Weidemanis JoakimExecutive Vice PresidentJul 27Option Exercise36.8719,834731,280112,548Jul 28 06:16 PM
Zerhouni Elias A.DirectorJul 27Option Exercise28.9811,014319,18634,809Jul 28 06:17 PM
Weidemanis JoakimExecutive Vice PresidentJul 27Sale196.0019,8343,887,46492,714Jul 28 06:16 PM
HEFNER LINDA PDirectorJul 27Sale197.002,754542,53829,995Jul 28 06:13 PM
COMAS DANIEL LEVPJul 27Sale200.878,0001,606,93796,933Jul 28 06:12 PM
COMAS DANIEL LEVPJul 24Option Exercise59.7888,9785,318,953163,911Jul 28 06:12 PM
Joyce Thomas Patrick JRPresident and CEOJul 24Option Exercise65.90181,39411,953,088302,851Jul 28 06:13 PM
SCHWIETERS JOHN TDirectorJul 24Option Exercise28.9811,014319,18625,394Jul 28 06:15 PM
SCHWIETERS JOHN TDirectorJul 24Sale193.956,0141,166,40319,380Jul 28 06:15 PM
Joyce Thomas Patrick JRPresident and CEOJul 24Sale193.98181,39435,186,837203,513Jul 28 06:13 PM
COMAS DANIEL LEVPJul 24Sale195.273,054596,3910Jul 28 06:12 PM
COMAS DANIEL LEVPJul 24Sale193.9788,97817,258,652104,933Jul 28 06:12 PM
RALES MITCHELL PChairman of Exec. CommitteeMay 29Buy164.69141,42023,291,0852,377,874Jun 02 04:30 PM
LOHR WALTER GDirectorMay 28Option Exercise28.9811,014319,18622,392May 29 05:11 PM
Blair RainerExecutive Vice PresidentMay 28Sale165.963,330552,63736,256May 29 05:13 PM
LOHR WALTER GDirectorMay 28Sale165.6111,0141,824,02911,378May 29 05:11 PM
COMAS DANIEL LEVPMay 18Sale165.6818,2593,025,078104,933May 19 05:11 PM
RALES MITCHELL PChairman of Exec. CommitteeMay 12Buy163.001,226199,8382,256May 12 04:12 PM
LUTZ ROBERT SSVP-Chief Accounting OfficerMay 08Option Exercise40.4528,3891,148,33547,339May 12 05:29 PM
Raskas DanielSVP-Corporate DevelopmentMay 08Option Exercise37.5129,0111,088,20348,734May 12 05:30 PM
Lalor Angela SSVP, Human ResourcesMay 08Sale163.038,0311,309,27035,910May 12 05:27 PM
Ellis Brian WSVP, GC & CCOMay 08Sale163.402,870468,96924,837May 12 05:27 PM
Raskas DanielSVP-Corporate DevelopmentMay 08Sale164.0937,0826,084,92919,723May 12 05:30 PM
LUTZ ROBERT SSVP-Chief Accounting OfficerMay 08Sale161.6833,8925,479,69618,950May 12 05:29 PM
SPOON ALAN GDirectorMar 20Option Exercise33.1819,912660,742111,293Mar 23 05:19 PM
DANIEL WILLIAM KEVPMar 04Sale147.5406594,384Mar 06 05:10 PM
King WilliamSVP, Strategic DevelopmentFeb 20Option Exercise44.0323,8081,048,23434,865Feb 24 06:21 PM
King WilliamSVP, Strategic DevelopmentFeb 20Sale160.2326,3704,225,19119,865Feb 24 06:21 PM
EHRLICH DONALD JDirectorFeb 10Option Exercise28.986,014174,286129,217Feb 11 05:51 PM
DANIEL WILLIAM KEVPFeb 10Sale163.2320,7333,384,31688,986Feb 12 05:13 PM
EHRLICH DONALD JDirectorFeb 10Sale163.136,014981,034123,203Feb 11 05:51 PM
Joyce Thomas Patrick JRPresident and CEOFeb 07Sale162.0320,4923,320,257157,694Feb 11 05:50 PM
COMAS DANIEL LEVPFeb 04Option Exercise56.7050,0002,835,000156,479Feb 05 08:43 PM
COMAS DANIEL LEVPFeb 04Sale163.2650,0008,162,950106,479Feb 05 08:43 PM
COMAS DANIEL LEVPFeb 03Option Exercise56.703,100175,770108,579Feb 04 08:46 PM
Lalor Angela SSVP, Human ResourcesFeb 03Option Exercise46.1318,267842,65756,782Feb 04 08:51 PM
McGrew MatthewEVP & Chief Financial OfficerFeb 03Option Exercise40.457,894319,31229,214Feb 04 08:53 PM
McGrew MatthewEVP & Chief Financial OfficerFeb 03Sale161.9811,3041,831,03021,320Feb 04 08:53 PM
Lalor Angela SSVP, Human ResourcesFeb 03Sale161.4918,2672,949,84638,515Feb 04 08:51 PM
COMAS DANIEL LEVPFeb 03Sale161.343,100500,167106,479Feb 04 08:46 PM
Blair RainerExecutive Vice PresidentJan 31Option Exercise57.1033,4671,910,81349,752Feb 04 08:45 PM
COMAS DANIEL LEVPJan 31Option Exercise57.9079,3644,595,176188,583Feb 04 08:46 PM
Joyce Thomas Patrick JRPresident and CEOJan 31Option Exercise62.82132,4748,321,445277,663Feb 04 08:49 PM
Joyce Thomas Patrick JRPresident and CEOJan 31Sale162.51132,47421,527,890195,608Feb 04 08:49 PM
COMAS DANIEL LEVPJan 31Sale161.5079,36412,817,492115,442Feb 04 08:46 PM
Blair RainerExecutive Vice PresidentJan 31Sale163.5036,4405,957,88127,313Feb 04 08:45 PM
RALES MITCHELL PChairman of Exec. CommitteeAug 23Buy139.522,500348,8003,030,453Aug 26 04:30 PM